First New York Securities’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

First New York Securities’s Portfolio ASTX Stock Details ASTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-88,500	Closed	-$751K	–	495
2013 Q3	$751K	Buy	+88,500	New	+$560K	0.3%	73

First New York Securities's ASTX Position: Q4 2013 in Review

First New York Securities sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 88,500 shares — an estimated $751K sold.

First New York Securities first reported a position in ASTX in Q3 2013 and held it in 1 quarter. The position peaked at $751K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

First New York Securities reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
First New York Securities sold 88,500 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $751K.
First New York Securities first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q3 2013 and held it in 1 quarter.
First New York Securities's ASTEX PHARMACEUTICALS, INC COM position peaked at $751K in Q3 2013.
0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on First New York Securities's 13F filing for Q4 2013, filed 12 Feb 2014.